45743-05-3

Basic information

• Product Name: 2-CHLORO-BENZAMIDINE
• Synonyms: 2-CHLORO-BENZAMIDINE;2-CHLORO-BENZAMIDINE HYDROCHLORIDE;2-Chlorobenzene-1-carboximidamide;2-CHLOR-BENZAMIDINE HYDROCHLORIDE;BenzenecarboxiMidaMide, 2-chloro-;2-ChlorobenziMidaMide
• CAS NO: 45743-05-3
• Molecular Formula: C₇H₇ClN₂
• Molecular Weight: 154.6
• Product Categories: pharmacetical
• Mol File: 45743-05-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 250.3°C at 760 mmHg
• Flash Point: 105.2°C
• Appearance: /
• Density: 1.29g/cm³
• Vapor Pressure: 0.0218mmHg at 25°C
• Refractive Index: 1.597
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-CHLORO-BENZAMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-BENZAMIDINE(45743-05-3)
• EPA Substance Registry System: 2-CHLORO-BENZAMIDINE(45743-05-3)

Safety Data

• Hazardous Substances Data: 45743-05-3(Hazardous Substances Data)

Usage

Uses

2-Chloro-benzamidine, HCl

InChI:InChI=1/C7H7ClN2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,(H3,9,10)

Upstream product

• 873-32-5 2-Chlorobenzonitrile 
• 56935-60-5 2-chloro-benzamide oxime 

Downstream Products

• 108444-60-6 2-(2-Chloro-phenyl)-5-vinyl-pyrimidine 
• 1025029-46-2 2-(2-chloro-phenyl)-pyrimidine-4,6-diol 
• 1025029-62-2 tert-butyl 3-(2-(2-chlorophenyl)-6-hydroxy-pyrimidin-4-yl)-azetidine-1-carboxylate 
• 1171113-79-3 2-[2-(2-chlorophenyl)-1H-imidazol-4-yl]-5-phenyloxazole 
• 609-66-5 2-chlorobenzamide 
• 14225-75-3 6-chloro-2-(2-chlorophenyl)benzimidazole 
• 14225-76-4 6-methyl-2-(2-chlorophenyl)benzimidazole 
• 23031-78-9 3-aminobenzisothiazole 
• 1059172-55-2 N-(2-(2-chlorophenyl)-5,6-dimethylpyrimidin-4-yl)-5-fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine 
• 404827-81-2 4-chloro-2-(2-chloro-phenyl)-5,6-dimethyl-pyrimidine 
• 1229380-49-7 C₇H₆BrClN₂ 
• 1059172-57-4 2-(2-chlorophenyl)-5,6-dimethylpyrimidin-4-ol 
• 83217-16-7 4,6-dichloro-2-(2-chlorophenyl)-pyrimidine 
• 670-83-7 2,4-diphenyl-1H-imidazole 

Relevant articles and documents

INHINITORS OF GLI1 AS THERAPEUTIC AGENTS

This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to glioma- associated oncogene (Gli) expression. More particularly, this disclosure relate

COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS

The present invention is directed to novel compounds of formula (I) and their use in treating metabolic diseases.

INHIBITORS OF HCV NS5B POLYMERASE

The present invention porivdes compounds of Formula I, compositons and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.